| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 50,623 | 54,971 | 57,402 | 56,354 | | Cost of Revenue | 47,479 | 47,570 | 48,965 | 47,849 | | | Gross Profit | 3,144 | 7,401 | 8,437 | 8,505 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,887 | 4,728 | 4,347 | 4,709 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,743) | 2,673 | 4,090 | 3,796 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | 16 | 14 | 19 | | Earnings Before Interest And Taxes | (1,736) | 2,689 | 4,104 | 3,815 | | Interest Expense | 267 | 221 | 225 | 268 | | Income Before Tax | (2,003) | 2,468 | 3,879 | 3,547 | | Income Tax Expense | (771) | 970 | 1,494 | 1,366 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,232) | 1,498 | 2,385 | 2,181 | | | Non-recurring Events | | Discontinued Operations | (200) | (1,032) | (48) | (62) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,432) | 466 | 2,337 | 2,119 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,432) | $466 | $2,337 | $2,119 |
|
0.21% Nasdaq 
Income Statement
